SCHEMBL3847074

SCHEMBL3847074

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncc(-c4noc(C5CC5)n4)n3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.38
TSHR P16473 4/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37
TUBB2A Q13885 1/20 0.37
TUBB8 Q3ZCM7 1/20 0.37
TUBA3E Q6PEY2 1/20 0.37
TUBA1A Q71U36 1/20 0.37
TUBA1C Q9BQE3 1/20 0.37
TUBB6 Q9BUF5 1/20 0.37
TUBB2B Q9BVA1 1/20 0.37
TUBB1 Q9H4B7 1/20 0.37
TGFBR1 P36897 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854699 0.92 MAPK14 (0.40) LMNATSHRALOX15MAPK1TGFBR1
SCHEMBL3846554 0.92 CNR2 (0.39) LMNATSHRALOX15MAPK1TGFBR1
SCHEMBL3845667 0.90 KIT (0.36) LMNATSHRALOX15MAPK1TGFBR1
SCHEMBL3848151 0.90 ALDH1A1 (0.38) LMNATSHRSMN1; SMN2MAPTHTT
SCHEMBL3848981 0.89 PIK3CA (0.33) TGFBR1KITPIK3CAPIK3CBMTOR
SCHEMBL3848861 0.88 ALDH1A1 (0.36) TGFBR1SMN1; SMN2MAPTALDH1A1PIK3CA
SCHEMBL3846800 0.88 CNR2 (0.39) KITGRM5CNR2PIK3CAPIK3CB
SCHEMBL3847653 0.88 KIT (0.36) TGFBR1KITCNR2PIK3CAPIK3CB
SCHEMBL3847508 0.87 PIK3CA (0.46) TGFBR1PIK3CAPIK3CBMTORCDK19
SCHEMBL3846856 0.86 CNR2 (0.36) LMNATSHRALOX15MAPK1KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed